Effects of etanercept in patients with the metabolic syndrome. - Wikidata - wikimedia - TriplyDB

Effects of etanercept in patients with the metabolic syndrome.

Effects of etanercept in patients with the metabolic syndrome.

http://www.wikidata.org/entity/Q35384380

about

"Control" laboratory rodents are metabolically morbid: why it matters Is the risk of cardiovascular disease altered with anti-inflammatory therapies? Insights from rheumatoid arthritis Role of cytokines and chemokines in non-alcoholic fatty liver disease Targeting inflammation in diabetes: Newer therapeutic options Adipokines - removing road blocks to obesity and diabetes therapy Inflammation, insulin resistance, and diabetes--Mendelian randomization using CRP haplotypes points upstream Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease.Obesity and upper airway control during sleep.Effects of TNF-alpha antagonism on E-selectin in obese subjects with metabolic dysregulation Association between systemic inflammation and incident diabetes in HIV-infected patients after initiation of antiretroviral therapy.Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome.Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in "healthy" men with metabolic syndrome Factors related to HIV-associated neurocognitive impairment differ with age.Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities Dietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART era.Effects of TNF-alpha neutralization on adipocytokines and skeletal muscle adiposity in the metabolic syndrome.Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage Regulation of LYRM1 gene expression by free fatty acids, adipokines, and rosiglitazone in 3T3-L1 adipocytes Therapeutic approaches to target inflammation in type 2 diabetes Innate and ozone-induced airway hyperresponsiveness in obese mice: role of TNF-α.Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.Inflammation as a Link between Obesity and Metabolic Syndrome.Nuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity.Eicosanoids and renal damage in cardiometabolic syndrome.Molecular targets related to inflammation and insulin resistance and potential interventions Inflammatory mechanisms in the regulation of insulin resistance.A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1 Metabolic syndrome in rheumatoid arthritis Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes Adipokines and the peripheral and neural control of energy balance.Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis.Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.Gene silencing in adipose tissue macrophages regulates whole-body metabolism in obese mice.Plasma levels of inflammatory cytokines in adult Nigerians with the metabolic syndrome Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.Paradoxical glucose-sensitizing yet proinflammatory effects of acute ASP administration in mice.Adipokines and hepatic insulin resistance Adipokines and insulin resistance

P2860

Q24599731-868608E7-6999-445D-BC48-E0D9172C35F1 Q26746659-D3453A28-8A0A-48D6-838C-F982D2E64644 Q26830328-0DACE309-0479-4DEE-9A8E-BCCF1F548A56 Q26852726-015E7C4A-F8E8-4390-9BDF-FB39769EA7D8 Q26995825-158AB805-8237-4C88-A54C-C946AE898993 Q28473422-5AD33445-80A0-4CB9-8EAD-E48213FCA244 Q33580624-BAD49871-E5E3-4447-A25D-AD1F5710467B Q33656629-6F4F21A9-752F-4561-B0B5-789CCAB493CA Q33937394-8B8E4D8A-B908-420F-B807-8B1A5C9220EB Q34153519-5465E212-CB69-41D3-AE2F-7A7CAA73FC0E Q34233328-F9D3CF18-8484-4A05-9E3D-4B04F7F8E7F6 Q34444895-A3A22452-BB97-4BFF-8877-6CD5835CCBA8 Q34571799-D418A5E6-C792-41A2-B28C-9913601495C9 Q34699554-1BC69FB0-09CF-462A-B0F0-E70FE44013C9 Q35058626-4C9C1138-4917-4E32-BEAC-0CEEE961AA20 Q35369261-2E37A885-D02E-4FD2-B882-8AE34DD89F75 Q35370152-877C9EE2-75F0-47E3-89FE-EBD7A6DB0AF1 Q35384250-14E82C69-AADD-4E26-BBE6-8231FF90DDBF Q35417136-DB0C3184-F73A-4DE0-B59E-2F5F9E890601 Q35495437-1E71BBB1-9243-4766-BD85-7493A717052E Q35581498-D9436B60-612C-4B36-AE65-6BE6E510E22A Q35672041-E6EC863E-2C2D-4150-85C3-49A16DF91F10 Q35829203-7EA93814-CBDC-4613-A2BC-31E1CF03CC88 Q35864675-BAB542C7-EF2E-4653-9D24-9D873FF7FCD4 Q35894344-E1171A02-8D50-4485-B39B-4882E50AD063 Q35947602-8AD22083-D5A4-4998-B46C-7055B02C0CA9 Q36294297-7CBC79E6-F101-446D-B6F8-CC86491BD790 Q36409227-5F61DF3D-E442-4853-913F-DD431D1455B1 Q36434758-9A85DA57-3FB7-4E19-804E-873E3FFA3071 Q36568868-DA95C598-7348-4EC9-AAC1-C08B1FD80E81 Q36588627-78353407-D8D6-417A-A583-50DF62982BCB Q36629302-D62E661A-37C0-4AFD-92C5-DD2BC16CC67F Q36633289-3F89E1EA-CF88-41DD-8524-4EBE2DB74ED7 Q36814772-87EFA308-BCBE-454F-A1AA-DC5BE4ED3216 Q36855257-9339E650-566E-42EB-AA9C-746F71F97087 Q36876733-051FCF46-8655-4399-AE42-52C04C233721 Q36879686-EDDDB011-A950-4329-82BC-30C021EDE7FC Q36882808-83ABDB46-8FC7-4AAB-9579-A5662BA36733 Q36896425-57C17741-7689-4D79-B8CB-4498A442F8D5 Q36972589-3767FC58-E52D-4522-B926-32F6EF64BA2F

P2860

Effects of etanercept in patients with the metabolic syndrome.

http://www.wikidata.org/entity/Q35384380

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Effects of etanercept in patients with the metabolic syndrome.

@ast

Effects of etanercept in patients with the metabolic syndrome.

@en

type

label

Effects of etanercept in patients with the metabolic syndrome.

@ast

Effects of etanercept in patients with the metabolic syndrome.

@en

prefLabel

Effects of etanercept in patients with the metabolic syndrome.

@ast

Effects of etanercept in patients with the metabolic syndrome.

@en

P1433

Q35384380-58FEEE4E-14A9-463D-9845-084AC95B23C2

P1476

Q35384380-BF62ED34-8D64-422B-908E-2D48A28B1D73

P2093

Q35384380-1352BA28-D5C7-41B5-83B3-20002FF22576

Q35384380-576A5834-15BA-4A11-AF6A-574FF2047261

Q35384380-6DEAE76B-F8CE-4B10-B5FA-CACD3746FC8A

Q35384380-AB324103-1BD0-4135-BCC1-BE9DEEFA1C51

Q35384380-DAAFD355-0AF8-406B-9EE6-F9D6B0E33878

P2860

Q35384380-0AB9A1D4-B78C-4367-AF0B-18A3DBFD8BD4

Q35384380-0C0C2C6F-2A68-464D-84E5-455980509194

Q35384380-0D9895F6-128E-4329-A7C9-676633865B0E

Q35384380-14BC1DF4-12A5-468F-9810-A32CECD5106E

Q35384380-1A335C58-FCBB-40C9-AACB-21A6512D37A1

Q35384380-1B5E2D29-7015-4827-B352-EFF28F4437F1

Q35384380-1F1F0567-9CB2-4B49-A041-3E6FFC7B7D1A

Q35384380-22F4C247-C75A-4269-890F-292531967A94

Q35384380-28E090DE-D29F-4781-B813-47330E360721

Q35384380-2A4752DC-AD39-4859-B338-22F0794C9AA5

P304

Q35384380-6A1ADF31-B7E5-42A1-86C8-93639874F0C2

P31

Q35384380-932BC261-E1F6-4AF0-92B4-3714DAAEF217

P356

Q35384380-569BE29B-C3A0-4635-A789-E6C2AE85372D

P407

Q35384380-5BADF505-10A4-4E46-A2AB-28C229E09A5A

P433

Q35384380-1786BDEC-5409-4D4A-8E5D-4B49AA204BEB

P478

Q35384380-21C530E5-C7E2-4A28-8031-3A3E84BB9DE7

P577

Q35384380-3A9810F5-2A2D-4C72-96AD-B6869CD5048D

P5875

Q35384380-50854E08-9592-4DD1-8370-AA2C22063446

P698

Q35384380-4574BB61-2D79-4FDD-A6D2-77E1CCE4BD90

P921

Q35384380-098CB969-4280-47D2-A92C-C85B1AE2109D

Q35384380-53A9CAE5-D32A-445E-BDDC-53F4D389F1FE

P932

Q35384380-BEFCE772-5856-4D67-9215-0E99C3032AFA

P356

ARCHINTE.166.8.902

P1433

JAMA Internal Medicine

P1476

Effects of etanercept in patients with the metabolic syndrome.

@en

P2093

Bridget Canavan

http://www.w3.org/2001/XMLSchema#string

Jacqueline Berry

http://www.w3.org/2001/XMLSchema#string

L Elizabeth Bernstein

http://www.w3.org/2001/XMLSchema#string

Steven K Grinspoon

http://www.w3.org/2001/XMLSchema#string

Sunnie Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

P304

902-908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTE.166.8.902

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7145048

http://www.w3.org/2001/XMLSchema#string

P698

16636217

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3196549

http://www.w3.org/2001/XMLSchema#string